Wednesday, June 15, 2005

Jazz, Schizophrenia, & Side Effects
NEW YORK - Side effects have taken center stage in the $14 billion market for schizophrenia drugs.

To understand why, take the case of Tom Harrell, a renowned jazz musician and composer. Harrell, dubbed "the greatest trumpeter of his generation" by Entertainment Weekly, is also schizophrenic. For years, he has fought not only his disease, but also the crippling side effects of the drugs used to treat it.

Compare that $14 billion to the $690 million Lilly is paying to settle claims against its Zyprexa brand, and you begin to get a sense of the scales involved here.


Post a Comment

<< Home